B Thompson to Survival Analysis
This is a "connection" page, showing publications B Thompson has written about Survival Analysis.
Connection Strength
0.033
-
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019 02; 7(2):154-162.
Score: 0.018
-
Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study. Intensive Care Med. 2017 Mar; 43(3):399-407.
Score: 0.016